发明授权
US07569230B2 Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
有权
α-肾上腺素能受体拮抗剂的稳定制剂及其用途
- 专利标题： Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
- 专利标题（中）： α-肾上腺素能受体拮抗剂的稳定制剂及其用途
-
申请号： US11611504申请日： 2006-12-15
-
公开(公告)号： US07569230B2公开(公告)日： 2009-08-04
- 发明人: Andrew X Chen , Julius Knowles , Eckard Weber
- 申请人： Andrew X Chen , Julius Knowles , Eckard Weber
- 申请人地址： US CA San Diego
- 专利权人： Novalar Pharmaceuticals, Inc.
- 当前专利权人： Novalar Pharmaceuticals, Inc.
- 当前专利权人地址： US CA San Diego
- 代理机构： Sterne, Kessler, Goldstein & Fox P.L.L.C.
- 主分类号： A61K9/08
- IPC分类号： A61K9/08 ; A61K31/417 ; A61K31/497 ; A61K47/12 ; A61K47/16 ; A61K47/26
摘要：
The present invention provides compositions and stable liquid formulations comprising alpha adrenergic receptor antagonists and use thereof for increasing blood flow. In one embodiment, the stable liquid formulations of this invention are useful for reversing the effects of an anesthetic agent, preferably a long-lasting local anesthetic agent administered in conjunction with an alpha adrenergic receptor agonist.
公开/授权文献
信息查询
